Common diabetes drug may shield pregnant women from dangerous blood pressure spike
NCT ID NCT03570632
Summary
This study is testing if adding the common diabetes medication metformin to usual care can help prevent dangerous high blood pressure disorders during pregnancy in women with type 1 diabetes. Researchers are enrolling 60 pregnant women with type 1 diabetes to take either metformin or a placebo daily starting before 20 weeks of pregnancy. The main goal is to see if metformin reduces the rate of pregnancy-related high blood pressure problems like preeclampsia.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS TYPE 1 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Magee Womens Hospital of UPMC
Pittsburgh, Pennsylvania, 15213, United States
Conditions
Explore the condition pages connected to this study.